27 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250327798514/en/Kairos-Pharma-Ltd.-Highlights-Participation-in-Recent-and-Upcoming-Scientific-and-Industry-Events
25 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/vast-granted-qualified-infectious-disease-product-designation-from-the-fda-302411166.html
14 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250313561475/en/Galderma-Successfully-Placed-an-Inaugural-EUR-500-Million-Single-Tranche-Eurobond-and-New-Dual-Tranche-CHF-435-Million-CHF-Bonds
13 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/splicebio-announces-first-patient-dosed-in-phase-12-astra-study-of-sb-007-a-dual-aav-gene-therapy-for-stargardt-disease-302400963.html
27 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/27/3034333/0/en/Pennant-Reports-Fourth-Quarter-and-Fiscal-Year-2024-Results.html
02 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/02/3003758/0/en/Pennant-Completes-Acquisition-of-Signature-Healthcare-at-Home-Assets.html